Figure 7
From: Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy

Results of GSEA enrichment analysis. enrichment in CHOL, THCA, UCEC using KEGG and HALLMARK gene sets.
From: Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Results of GSEA enrichment analysis. enrichment in CHOL, THCA, UCEC using KEGG and HALLMARK gene sets.